Nifedipine (Adalat)

4704  relevant articles (547 outcomes, 838 trials/studies) found for this Drug

Adalat; AWD Pharma Brand of Nifedipine; Adcock Ingram Brand of Nifedipine; BAY-a-1040; Bay-1040; Bayer Brand of Nifedipine; Cordipin; Cordipine; Corinfar; Fenigidin; KRKA Brand of Nifedipine; Korinfar; Nifangin; Nifedipine Monohydrochloride; Nifedipine-GTIS; Orion Brand of Nifedipine; Pfizer Brand of Nifedipine; Procardia; Procardia XL; Vascard; BAY a 1040; BAYa1040; Bay 1040; Bay1040; Monohydrochloride, Nifedipine; Nifedipine Bayer Brand; Nifedipine GTIS; Nifedipine KRKA Brand; Nifedipine Orion Brand; Nifedipine Pfizer Brand; 3,5-Pyridinedicarboxylic acid, 1,4-dihydro-2,6-dimethyl-4-(2-nitrophenyl)-, dimethyl ester

Relationship Network

Drug Context: Research Results

Experts

1.	Wagener, Gilbert: 5 articles (08/2007 - 03/2003)
2.	Landen, Harald: 5 articles (03/2007 - 07/2005)
3.	Hosoda, Saichi: 4 articles (10/2007 - 01/2002)
4.	Kirwan, Bridget-Anne: 4 articles (08/2007 - 03/2005)
5.	de Brouwer, Sophie: 4 articles (08/2007 - 03/2005)
6.	Poole-Wilson, Philip A: 4 articles (08/2007 - 03/2005)
7.	Yui, Yoshiki: 3 articles (10/2007 - 03/2004)
8.	Sumiyoshi, Tetsuya: 3 articles (10/2007 - 01/2002)
9.	Lubsen, Jacobus: 3 articles (08/2007 - 03/2005)
10.	Flynn, Joseph T: 3 articles (07/2005 - 06/2002)

Related Diseases

1.	Hypertension (High Blood Pressure) 01/01/1998 - "The results obtained show that Adalat in dosage 60 mg daily during 7 days is most effective in cases with concomitant border-line hypertension. " 01/01/1991 - "Nifedipine turned out most effective in patients of functional class II with arterial hypertension." 01/01/2007 - "The dose-dependent increased efficacy and the markedly improved safety profile of bedtime as compared to morning administration of nifedipine GITS should be taken into account when prescribing this CCB in the treatment of essential hypertension." 12/01/1987 - "In hypertension a similar antihypertensive effect to nifedipine has been found, while a significantly greater lowering of blood pressure was seen than that obtained with a diuretic. " 01/01/1986 - "The efficacy of corinfar therapy was higher in the patients with hypertension with a high initial tension of the peripheral vessels." Order ALL the reference details at left...
2.	Angina Pectoris 01/01/2006 - "Professor Hashimoto demonstrated that nifedipine could increase coronary blood flow even in extremely low dosages, and Professor Kimura found that nifedipine is highly efficacious in preventing anginal attacks in patients with angina pectoris, particularly those with variant form of angina. " 01/01/1987 - "For patients with angina pectoris, a plasma concentration range that is associated with optimal treatment has not been defined, since large inter-individual variations in the nifedipine plasma concentration were observed in effectively treated patients. " 08/01/1990 - "These salutary hemodynamic responses of nifedipine appear to be beneficial for patients with effort angina pectoris." 01/16/1989 - "Results from a 14-week, open-label, crossover multicenter trial completed by 91 patients with chronic stable angina pectoris demonstrate that patients treated with standard nifedipine capsules may be switched to equivalent total 24-hour doses of nifedipine GITS and achieve comparable or improved efficacy (due to improved compliance) with a more favorable side-effects profile. " 04/01/1988 - "To assess the dosing equivalency and the early and late antianginal efficacy of a gastrointestinal therapeutic system for once-daily, continuous-release nifedipine (N-GITS), 10 patients with stable angina pectoris, who were previously receiving chronic treatment with nifedipine, completed a 12-week trial comparing N-GITS with standard nifedipine. " Order ALL the reference details at left...
3.	Ischemia 04/01/1997 - "RESULTS: Endothelium-dependent relaxation after ischemia was significantly improved with all three drugs in a dose-dependent fashion; nifedipine was found to be the more potent. " 11/01/1993 - "Nifedipine therapy (immediate release) was effective in control of ischemia only when both ambulatory and office-measured blood pressure were controlled." 11/01/1993 - "The aims of this study were 1) to evaluate the role of blood pressure and associated neural tonicity in ambient ischemia of a group of hypertensive patients with stable angina, and 2) to determine the efficacy of immediate release nifedipine therapy in controlling the total ischemic burden in both office-measured and ambulatory blood pressure. " 12/01/1995 - "3. A 6-wk nifedipine treatment improved post-ischemic recovery of cardiac parameters and prevented myocardial Na+ accumulation after ischemia and myocardial Ca2+ level and water content elevation after reperfusion of diabetic rats. " 10/01/1989 - "The vasomotor influences of nifedipine on these lesions are variable as well as the efficacy of the drug on the manifestations of ischemia at rest.(ABSTRACT TRUNCATED AT 250 WORDS)" Order ALL the reference details at left...
4.	Myocardial Ischemia (Ischemic Heart Diseases) 09/01/1991 - "Thus, asymptomatic ischemic episodes more frequently occur than symptomatic episodes and the administration of slow-release nifedipine is highly effective in suppressing not only symptomatic but also asymptomatic myocardial ischemia in patients with variant angina. " 03/25/1988 - "Group II had improvement in 40% of areas, of significantly worsened areas in 6%, and unchanged areas in 54%, in both groups myocardial ischemia was reduced by therapy, but ISDN improved myocardial perfusion to a considerably greater extent than did nifedipine." 01/01/1982 - "In our patients with CAD, improved RMBF appears to be related to a decrease in coronary vascular tone and suggests a physiologic basis for the beneficial effect of nifedipine in ischemic heart disease." 04/01/1983 - "In patients with ischemic heart disease and impaired ventricular function, in addition to an improvement in systolic function, single-dose nifedipine administration led to favorable effects on diastolic function with a shift of the diastolic pressure-volume relationship downward and to the diastolic pressure-volume relationship downward and to the left. " 01/01/1988 - "We conclude that both nifedipine and ISMN in slow-release formulations are equally effective in the treatment of myocardial ischemia. " Order ALL the reference details at left...
5.	Spasm (Spasms) 07/01/1983 - "Thus, patients with coronary spasm selected because of a favorable short-term response to nifedipine were effectively treated over the long term with nifedipine; however, additional therapy was often needed to control symptoms. " 11/01/1985 - "In 1 patient, nifedipine was effective in prolonging exercise tolerance by preventing the occurrence of coronary spasm and by increasing blood supply to the ischemic region during exercise." 10/01/1982 - "In certain selected patients in whom coronary artery spasm is responsible for myocardial collapse, the drug nifedipine may be effective in relieving this spasm and allowing for myocardial recovery." 10/22/1979 - "Nifedipine appears to be effective in the management of patients with symptomatic coronary arterial spasm and normal or mildly abnormal coronary arteriograms. " 01/01/1987 - "We have used a placebo controlled trial to investigate the effect of long-term administration of nifedipine in the prevention of symptomatic episodes of oesophageal spasm. " Order ALL the reference details at left...

Related Drugs and Biologics

1.	Verapamil (Calan)
2.	Calcium
3.	Propranolol (Inderal)
4.	Diltiazem (Cardizem)
5.	Calcium Channels (Calcium Channel)
6.	Atenolol (Tenormin)
7.	Amlodipine (Norvasc)
8.	Captopril (Capoten)
9.	Isosorbide Dinitrate (Isordil)
10.	Nitroglycerin (Dynamite)

Related Therapies and Procedures

1.	Tocolysis
2.	Aftercare (After-Treatment)
3.	Transplants (Transplant)
4.	Drug Therapy (Chemotherapy)
5.	Lithotripsy (Extracorporeal Shockwave Lithotripsy)